GB1529607A - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number
GB1529607A
GB1529607A GB36380/76A GB3638076A GB1529607A GB 1529607 A GB1529607 A GB 1529607A GB 36380/76 A GB36380/76 A GB 36380/76A GB 3638076 A GB3638076 A GB 3638076A GB 1529607 A GB1529607 A GB 1529607A
Authority
GB
United Kingdom
Prior art keywords
hormone
prolinamide
histidyl
carbonyl
oxooxazolidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB36380/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50109777A external-priority patent/JPS5234914A/ja
Priority claimed from JP2829076A external-priority patent/JPS52110816A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GB1529607A publication Critical patent/GB1529607A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/066TRH, thyroliberin, thyrotropin releasing hormone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB36380/76A 1975-09-09 1976-09-02 Medicinal composition Expired GB1529607A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50109777A JPS5234914A (en) 1975-09-09 1975-09-09 Method and composition for preventing failing of milk secretion of live stocks
JP2829076A JPS52110816A (en) 1976-03-15 1976-03-15 Medicines

Publications (1)

Publication Number Publication Date
GB1529607A true GB1529607A (en) 1978-10-25

Family

ID=26366350

Family Applications (1)

Application Number Title Priority Date Filing Date
GB36380/76A Expired GB1529607A (en) 1975-09-09 1976-09-02 Medicinal composition

Country Status (8)

Country Link
US (1) US4112073A (enExample)
AU (1) AU504840B2 (enExample)
CA (1) CA1073359A (enExample)
DE (1) DE2640322A1 (enExample)
FR (1) FR2323397A1 (enExample)
GB (1) GB1529607A (enExample)
NL (1) NL7609935A (enExample)
NZ (1) NZ181966A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6047244B2 (ja) * 1977-01-05 1985-10-21 武田薬品工業株式会社 薬剤
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
IT1218472B (it) * 1985-08-30 1990-04-19 Alfio Bertolini Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria
DE4318398A1 (de) * 1993-06-03 1994-12-08 Merck Patent Gmbh Dexamethasonphosphat zur Infusionstherapie
US5614511A (en) * 1996-03-11 1997-03-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for treating itchy skin
US7812009B2 (en) * 2002-12-16 2010-10-12 Intervet International B.V. Mastitis treatment
CN100406063C (zh) * 2005-05-18 2008-07-30 陈凌 外敷用抗甲状腺软膏及其制备方法
US20160296536A1 (en) * 2015-04-13 2016-10-13 Animal Biotech, LLC Administration of Glucocorticoid Steroids to Livestock

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3503951A (en) * 1965-06-15 1970-03-31 Ciba Geigy Corp Complexes of a.c.t.h. peptides with polyglutamic and polyaspartic acid
JPS5714337B2 (enExample) 1973-02-23 1982-03-24

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function

Also Published As

Publication number Publication date
FR2323397A1 (fr) 1977-04-08
AU1731776A (en) 1978-03-09
AU504840B2 (en) 1979-11-01
US4112073A (en) 1978-09-05
NL7609935A (nl) 1977-03-11
CA1073359A (en) 1980-03-11
FR2323397B1 (enExample) 1980-10-24
DE2640322A1 (de) 1977-03-17
NZ181966A (en) 1978-04-28

Similar Documents

Publication Publication Date Title
US3568828A (en) Modified sequential oral contraceptive
IE42692L (en) Oestrogenic compositions
IL49095A (en) 1,4dihydropyridine-3,5-di-carboxylic acid aralkyl esters their preparation and pharmaceutical compositions containing them
NZ177159A (en) Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
GB1500374A (en) Oral pharmaceutical preparation
GB1529607A (en) Medicinal composition
NZ193984A (en) Nona- and deca- peptide analogues of luteinizing hormone releasing hormone and pharmaceutical compositions
IL47645A (en) Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
NZ179055A (en) Peptide analogues of lh-reeasing hormone pharmaceutical and vetterinary compositions
IE41287L (en) Steroid pharmaceutical composition
IL50507A0 (en) Phenoxyalkylcarboxylic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ES379001A1 (es) Procedimiento para la obtencion de composiciones a base de soluciones acuosas estables de fosfatos de esteroides.
GB1488995A (en) Compositions containing anti-androgenic compounds
IL49132A0 (en) New steroids of the androstane series,their preparation and pharmaceutical compositions containing them
GB1442159A (en) Pharmaceutical compositions containing paracetamol
GB1231412A (enExample)
IL45344A0 (en) 16alpha-methyl-pregna-1,4,9(11)-triene-3,20-diones as medicaments,new processes for the preparation of these products,and pharmaceutical compositions
GB1483650A (en) Pharmaceutical preparations based on mesterolone
GB1132317A (en) Therapeutic compositions
GB1474749A (en) Pharmaceutical preparations based on cyproterone
ZA796194B (en) New 2,2-dimethyl 19-nor steroid derivatives,process for their preparation,their application as medicaments and pharmaceutical compositions containing them
GB1300516A (en) Pharmaceutical compositions with a vitamin a activity
EP0003090A3 (en) 17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them
GB1429977A (en) Diuretic composition
GB1300486A (en) Compositions for the treatment of respiratory ailments in man

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee